One representative patient with a favorable therapeutic response after 2 cycles of 177Lu-FAPI-RGD. (IMAGE)
Caption
Figure 1. One representative patient with a favorable therapeutic response after 2 cycles of 177Lu-FAPI-RGD. A 56-year-old woman with disease progression after surgery received 177Lu-FAPI-RGD RLT at 2.2 GBq/cycle. Baseline 68Ga-FAPI-RGD PET/CT revealed intense 177Lu-FAPI-RGD uptake in most metastatic lesions including lymph node and lung modules (left, arrows and square box). After 2 treatment cycles, restaging 68Ga-FAPI-RGD PET/CT revealed a significant reduction in tumor size in most of the metastatic lesions. Furthermore, most of the lesions in the lungs have disappeared (right, arrows and square box).
Credit
Image created by Jialin Xiang et al., Peking Union Medical College Hospital (Beijing, China) and National University of Singapore (Singapore), PhD Student.
Usage Restrictions
Please give appropriate credit.
License
Original content